Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Rheumatology | 3 | 2021 | 1213 | 0.93 | Why? |
| Rheumatic Diseases | 4 | 2021 | 2675 | 0.90 | Why? |
| Antirheumatic Agents | 6 | 2021 | 3023 | 0.77 | Why? |
| Multiple Sclerosis | 4 | 2018 | 2600 | 0.54 | Why? |
| Genetic Predisposition to Disease | 3 | 2017 | 4027 | 0.52 | Why? |
| Body Mass Index | 2 | 2017 | 4306 | 0.52 | Why? |
| Arthritis, Rheumatoid | 4 | 2021 | 2043 | 0.50 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.35 | Why? |
| HLA-DRB1 Chains | 3 | 2018 | 196 | 0.34 | Why? |
| Smoking | 2 | 2017 | 3358 | 0.33 | Why? |
| Glucocorticoids | 2 | 2021 | 4431 | 0.29 | Why? |
| Mendelian Randomization Analysis | 2 | 2017 | 317 | 0.27 | Why? |
| Lupus Erythematosus, Systemic | 3 | 2020 | 1380 | 0.26 | Why? |
| Autoimmune Diseases | 1 | 2017 | 1996 | 0.26 | Why? |
| Vitamin D | 1 | 2017 | 2904 | 0.22 | Why? |
| Skin Diseases | 1 | 2017 | 2509 | 0.21 | Why? |
| Spondylarthropathies | 1 | 2020 | 163 | 0.19 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.17 | Why? |
| Prednisone | 1 | 2020 | 652 | 0.15 | Why? |
| HLA-A Antigens | 1 | 2017 | 196 | 0.15 | Why? |
| Age of Onset | 1 | 2017 | 557 | 0.14 | Why? |
| Janus Kinase Inhibitors | 1 | 2020 | 682 | 0.14 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.13 | Why? |
| Arthritis, Psoriatic | 1 | 2020 | 625 | 0.13 | Why? |
| Registries | 4 | 2021 | 12327 | 0.13 | Why? |
| Vasculitis | 1 | 2020 | 691 | 0.13 | Why? |
| Sweden | 2 | 2017 | 1969 | 0.13 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.12 | Why? |
| Patient Safety | 2 | 2019 | 4885 | 0.12 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.12 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 1454 | 0.10 | Why? |
| Gait Disorders, Neurologic | 1 | 2010 | 64 | 0.10 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.10 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.09 | Why? |
| Risk Factors | 6 | 2020 | 71621 | 0.09 | Why? |
| Environmental Exposure | 1 | 2018 | 1558 | 0.08 | Why? |
| Gene-Environment Interaction | 2 | 2018 | 127 | 0.08 | Why? |
| Case-Control Studies | 4 | 2020 | 17671 | 0.08 | Why? |
| Disabled Persons | 1 | 2017 | 1152 | 0.08 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.08 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.08 | Why? |
| Male | 13 | 2021 | 367725 | 0.07 | Why? |
| Female | 13 | 2021 | 380317 | 0.07 | Why? |
| Biological Products | 1 | 2020 | 2331 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| Aged | 10 | 2021 | 215776 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| Risk | 1 | 2017 | 5288 | 0.07 | Why? |
| Adult | 9 | 2021 | 244371 | 0.07 | Why? |
| Humans | 17 | 2021 | 930598 | 0.07 | Why? |
| Robotics | 1 | 2010 | 528 | 0.07 | Why? |
| United States | 3 | 2021 | 46150 | 0.06 | Why? |
| Health Status Disparities | 1 | 2021 | 4072 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.06 | Why? |
| Ambulatory Care | 1 | 2019 | 4947 | 0.06 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2019 | 6331 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.05 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.05 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.05 | Why? |
| Parkinson Disease | 1 | 2010 | 1414 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Pesticides | 1 | 2018 | 100 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| American Heart Association | 1 | 2017 | 347 | 0.04 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.03 | Why? |
| New York | 1 | 2020 | 2488 | 0.03 | Why? |
| Hip | 1 | 2010 | 29 | 0.03 | Why? |
| Knee | 1 | 2010 | 35 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Psychomotor Performance | 1 | 2010 | 110 | 0.03 | Why? |
| Biomechanical Phenomena | 1 | 2010 | 291 | 0.02 | Why? |
| Physical Education and Training | 1 | 2010 | 110 | 0.02 | Why? |
| Aged, 80 and over | 2 | 2017 | 88759 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.02 | Why? |
| Accidental Falls | 1 | 2010 | 448 | 0.02 | Why? |
| Retrospective Studies | 1 | 2017 | 105322 | 0.02 | Why? |
| Electronic Health Records | 1 | 2019 | 3492 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.02 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.01 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 5002 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| Quality of Life | 1 | 2010 | 9820 | 0.01 | Why? |
| Treatment Outcome | 1 | 2010 | 51732 | 0.00 | Why? |
| Surveys and Questionnaires | 1 | 2010 | 43792 | 0.00 | Why? |
Gianfrancesco's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(93)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(99)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_